In the last few decades, the ever-increasing improvements in cancer detection have allowed urologists to detect prostate cancer (PrC) at earlier stages: currently, in industrialised countries, most diagnosed prostate tumours are small and localised. 1 As a direct consequence, health-related quality of life (QoL) has become a prominent factor in treatment decision-making for localised PrC. Indeed, approaches such as radical prostatectomy (RP) and external beam therapy have been associated with significantly impaired urinary, bowel,
CITATION STYLE
Charles, C., de la Rosette, J., & Emberton, M. (2015). Pushing the Limits with Nanoknife®: A Promising New Technology in Localised Prostate Cancer Management. EMJ Allergy & Immunology, 90–102. https://doi.org/10.33590/emjurol/10311671
Mendeley helps you to discover research relevant for your work.